London, United Kingdom

Chris Marshall



Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chris Marshall in Cancer Research

Introduction: Chris Marshall is a prominent inventor based in London, GB, recognized for his significant contributions to cancer research through his innovative patented methods. With two patents to his name, he plays a pivotal role in advancing medical science and improving cancer diagnosis and treatment.

Latest Patents: Chris Marshall's latest patents focus on groundbreaking methods for the detection of the oncogenic T1796A B-Raf mutation. This invention relates to mutations in B-Raf gene products, which have been identified in human tumors of natural origin. These mutations are associated with cancerous phenotypes and serve as a vital basis for diagnosing cancer, identifying cancerous cells, and evaluating predispositions to cancer in human subjects. Additionally, his patent on B-raf polynucleotides underscores the same critical aspects, aiming to support the development of effective anti-cancer therapeutics.

Career Highlights: As an inventor, Chris Marshall's work has been highly influential, particularly in the realm of oncology. His innovative approaches have paved the way for more accurate diagnostic techniques and therapeutic strategies, which are integral in the fight against cancer. His contributions have enhanced the understanding of genetic mutations and their roles in cancer progression.

Collaborations: Chris Marshall has had the privilege of collaborating with notable peers in the field, including Mike Stratton and Andy Futreal. Their collective expertise and joint efforts have been instrumental in propelling research forward and fostering advancements in cancer detection and treatment methodologies.

Conclusion: Chris Marshall stands out as a key figure in the intersection of innovation and healthcare. His patents reflect not only his inventiveness but also his dedication to addressing significant health challenges. Through his work with The Wellcome Trust Limited and his collaborations with esteemed colleagues, he continues to make impactful contributions that are vital for improving cancer care and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…